Pubmed    Pubmed Central
uBio Home | uBioRSS

WebSearchLiteratureMolecularImages

 uBio  Web Results 1 - 10 of about 348

Synonyms:
   Apollonia 

Broader Terms:
   Gobiidae (gobies) 
   Unassigned 

More Specific:
   Apollonia fluviatilis 
   Apollonia melanostoma 
   Apollonia melanostomus 
 
 
Latest Articles on Apollonia from uBioRSS
Primary and secondary sexual characters in alternative reproductive tactics... - ScienceDirect Search: species
Detection of temporal trends of ?- and ?-chlordane in Lake Erie fish commun... - ScienceDirect Search: species


External Resources:

Did you mean: Apollon, Apolon, Apolonia, Appollon or Appolonius?



1.  Adipose-Derived Mesenchymal Stem Cells do not Affect the Invasion and Migration Potential of Oral Squamous Carcinoma Cells.LinkIT
Sinha S, Narjus-Sterba M, Tuomainen K, Kaur S, Seppänen-Kaijansinkko R, Salo T, Mannerström B, Al-Samadi A
International journal of molecular sciences, 2020
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0

2.  Bioarchaeological reconstruction of physiological stress during social transition in Albania.LinkIT
Kyle B, Shehi E, Koçi M, Reitsema LJ
International journal of paleopathology, 2020
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0

3.  Is the technical quality of root fillings associated with socioeconomic status? A cross-sectional study among Finnish adults.LinkIT
Raittio E, Huumonen S, Suominen AL
European journal of oral sciences Eur. J. Oral Sci. Is the technical quality of root fillings associated with socioeconomic status? A cross-sectional study among Finnish adults. 10.1111/eos.12730 We investigated differences in the technical quality of root fillings according to socioeconomic status. In the Finnish Health 2000 Survey, which comprised a sample of 8,028 adults aged over 29 yr, 6,115 underwent panoramic radiography. A total of 7,986 endodontically treated teeth were detected among 3,095 participants. The criterion for a technically inadequate root filling was a distance from the root filling to the root apex of over 3 mm or a filling extruding beyond the apex. Educational level, employment status, and income were the measures of socioeconomic status. Differences in the frequency of inadequate root fillings according to socioeconomic status were investigated using a multilevel logistic mixed-effects model taking into account age, gender, number of teeth, and type of root filled tooth. Almost half (46%) of the root fillings were inadequate. Among the over 64-yr-olds, higher education and higher income were associated with a higher probability of having an inadequate root filling. Among the under 65-yr-olds, socioeconomic status was not associated with root filling quality. Contrary to expectation, lower socioeconomic status was not associated with poorer endodontic treatment quality; however, higher income and higher education was associated with higher odds for inadequate root fillings among the over 64-yr-olds. © 2020 The Authors. Eur J Oral Sci published by John Wiley & Sons Ltd. Raittio Eero E https://orcid.org/0000-0002-9258-9355 Institute of Dentistry, University of Eastern Finland, Kuopio, Finland. Huumonen Sisko S Institute of Dentistry, University of Eastern Finland, Kuopio, Finland. Diagnostic Imaging Center, Kuopio University Hospital, Kuopio, Finland. Research Unit of Oral Health Sciences, University of Oulu, Oulu, Finland. Suominen Anna L AL Institute of Dentistry, University of Eastern Finland, Kuopio, Finland. Department of Oral and Maxillofacial Diseases, Kuopio University Hospital, Kuopio, Finland. Public Health Evaluation and Projection Unit, Finnish Institute for Health and Welfare (THL), Helsinki, Finland. eng 20200050 Suomen Hammaslääkäriseura Apollonia Journal Article 2020 08 09 England Eur J Oral Sci 9504563 0909-8836 D IM dental digital radiography disparities endodontics quality of care root canal obturation 2020 07 09 2020 8 11 6 0 2020 8 11 6 0 2020 8 11 6 0 aheadofprint 32776471 10.1111/eos.12730 References, 2020</i></font><br><font color=#008000>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0<br></font></span><br>4.  <a href=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0 class=title>Antitumoral Drug: Loaded Hybrid Nanocapsules Based on Chitosan with Potential Effects in Breast Cancer Therapy.</a><a href=http://ubio.org/tools/linkit.php?map%5B%5D=all&link_type=2&url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0><img src=linkit.png border=0 title='LinkIT' alt='LinkIT'></a> <br><span class=j>Dellali KZ, Rata DM, Popa M, Djennad M, Ouagued A, Gherghel D<br><font color=gray><i>International journal of molecular sciences, 2020</i></font><br><font color=#008000>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0<br></font></span><br>5.  <a href=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0 class=title>Risk of scarring in Gianotti Crosti syndrome.</a><a href=http://ubio.org/tools/linkit.php?map%5B%5D=all&link_type=2&url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0><img src=linkit.png border=0 title='LinkIT' alt='LinkIT'></a> <br><span class=j>Chiriac A, Podoleanu C, Stolnicu S<br><font color=gray><i>Minerva pediatrica, 2020</i></font><br><font color=#008000>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0<br></font></span><br>6.  <a href=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0 class=title>Randomized controlled and double-blinded study of Caphosol versus saline oral rinses in pediatric patients with cancer.</a><a href=http://ubio.org/tools/linkit.php?map%5B%5D=all&link_type=2&url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0><img src=linkit.png border=0 title='LinkIT' alt='LinkIT'></a> <br><span class=j>Immonen E, Aine L, Nikkilä A, Parikka M, Grönroos M, Vepsäläinen K, Palmu S, Helminen M, Peltomäki T, Lohi O<br><font color=gray><i>Pediatric blood & cancer Pediatr Blood Cancer Randomized controlled and double-blinded study of Caphosol versus saline oral rinses in pediatric patients with cancer. e28520 10.1002/pbc.28520 Oral mucositis (OM) is a significant side effect of cancer treatment. The purpose of this study was to compare topically administered Caphosol to saline rinses in the prevention of mucositis in pediatric cancer patients. A controlled, double-blinded, and randomized clinical crossover study recruited patients between 2 to 17.99 years of age who were diagnosed with a malignancy and were receiving either high-dose methotrexate (?1 g/m2 ), anthracycline, or cisplatin chemotherapy (NCT0280733). All patients received two 7-day cycles of the mouth rinses; that is, one cycle of Caphosol and one cycle of saline in a randomized order. Oral changes and symptoms were evaluated using the World Health Organisation (WHO) toxicity scale and the Children's International Mucositis Evaluation Scale (ChIMES). The primary endpoint was the frequency and severity of OM and oral symptoms. A total of 56 patients were recruited to the study, of whom 45 were randomized with a median age of 6.5 years (range 2.1-17.1 years). No cases of severe OM were observed. Grade ? 3 oral symptoms were present at least once in six (13%) patients during the Caphosol cycle and 13 (29%) patients during the saline cycle (P = .12). The peak of symptom scores was evident at around day 4-7 after administration of the chemotherapy with no marked differences between the rinse solutions. Multivariable regression analysis did not indicate a benefit of using Caphosol over the saline solution. No difference in prevention of oral mucositis was observed between the use of Caphosol or saline rinses. © 2020 Wiley Periodicals LLC. Immonen Egle E https://orcid.org/0000-0001-6234-3509 Tampere Center for Child Health Research, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland. Department of Ear and Oral Diseases, Tampere University Hospital, Tampere, Finland. Aine Liisa L Department of Ear and Oral Diseases, Tampere University Hospital, Tampere, Finland. Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland. Nikkilä Atte A Tampere Center for Child Health Research, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland. Parikka Mataleena M Department of Ear and Oral Diseases, Tampere University Hospital, Tampere, Finland. Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland. Grönroos Marika M Department of Pediatrics, Turku University Hospital, Turku, Finland. Vepsäläinen Kaisa K Department of Pediatrics, Kuopio University Hospital, Kuopio, Finland. Palmu Sauli S Tampere Center for Child Health Research, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland. Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland. Helminen Mika M Research, Development and Innovation Centre, Tampere University Hospital, Tampere, Finland. Faculty of Social Sciences, Health Sciences, Tampere University, Tampere, Finland. Peltomäki Timo T Department of Ear and Oral Diseases, Tampere University Hospital, Tampere, Finland. Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland. Institute of Dentistry, University of Eastern Finland, Kuopio, Finland. Lohi Olli O Tampere Center for Child Health Research, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland. Tays Cancer Centre, Tampere University Hospital, Tampere, Finland. eng MK244 Competitive State Research Financing of the Expert Responsibility area of Tampere University Hospital 9V033 Competitive State Research Financing of the Expert Responsibility area of Tampere University Hospital Apollonia Foundation The Pediatric Cancer Foundation Väre Journal Article 2020 07 29 United States Pediatr Blood Cancer 101186624 1545-5009 IM Caphosol mucositis prevention randomized saline 2020 05 15 2020 06 04 2020 7 30 6 0 2020 7 30 6 0 2020 7 30 6 0 aheadofprint 32725875 10.1002/pbc.28520 REFERENCES, 2020</i></font><br><font color=#008000>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0<br></font></span><br>7.  <a href=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0 class=title>Drug Delivery System Based on pH-Sensitive Biocompatible Poly(2-vinyl pyridine)-b-poly(ethylene oxide) Nanomicelles Loaded with Curcumin and 5-Fluorouracil.</a><a href=http://ubio.org/tools/linkit.php?map%5B%5D=all&link_type=2&url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0><img src=linkit.png border=0 title='LinkIT' alt='LinkIT'></a> <br><span class=j>Iurciuc-Tincu CE, Cretan MS, Purcar V, Popa M, Daraba OM, Atanase LI, Ochiuz L<br><font color=gray><i>Polymers, 2020</i></font><br><font color=#008000>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0<br></font></span><br>8.  <a href=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0 class=title>Risk stratification in oral squamous cell carcinoma using staging of the eighth American Joint Committee on Cancer: Systematic review and meta-analysis.</a><a href=http://ubio.org/tools/linkit.php?map%5B%5D=all&link_type=2&url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0><img src=linkit.png border=0 title='LinkIT' alt='LinkIT'></a> <br><span class=j>Almangush A, Pirinen M, Youssef O, Mäkitie AA, Leivo I<br><font color=gray><i>Head & neck Head Neck Risk stratification in oral squamous cell carcinoma using staging of the eighth American Joint Committee on Cancer: Systematic review and meta-analysis. 10.1002/hed.26344 The eighth edition of the American Joint Committee on Cancer (AJCC8) staging manual has major changes in oral squamous cell carcinoma (OSCC). We searched PubMed, OvidMedline, Scopus, and Web of Science for studies that examined the performance of AJCC8 in OSCC. A total of 40?808 patients were included in the studies of our meta-analysis. A hazard ratio (HR) of 1.87 (95%CI 1.78-1.96) was seen for stage II, 2.65 (95%CI 2.51-2.80) for stage III, 3.46 (95%CI 3.31-3.61) for stage IVa, and 7.09 (95%CI 4.85-10.36) for stage IVb. A similar gradual increase in risk was noted for the N classification. For the T classification, however, there was a less clear variation in risk between T3 and T4. AJCC8 provides a good risk stratification for OSCC. Future research should examine the proposals introduced in the published studies to further improve the performance of AJCC8. © 2020 The Authors. Head & Neck published by Wiley Periodicals, Inc. Almangush Alhadi A https://orcid.org/0000-0003-4106-314X Department of Pathology, University of Helsinki, Helsinki, Finland. Research Program in Systems Oncology, Faculty of Medicine, University of Helsinki, Helsinki, Finland. Institute of Biomedicine, Pathology, University of Turku, Turku, Finland. Faculty of Dentistry, University of Misurata, Libya. Pirinen Matti M Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland. Department of Public Health, University of Helsinki, Helsinki, Finland. Department of Mathematics and Statistics, University of Helsinki, Helsinki, Finland. Youssef Omar O Department of Pathology, University of Helsinki, Helsinki, Finland. Research Program in Systems Oncology, Faculty of Medicine, University of Helsinki, Helsinki, Finland. Mäkitie Antti A AA https://orcid.org/0000-0002-0451-2404 Research Program in Systems Oncology, Faculty of Medicine, University of Helsinki, Helsinki, Finland. Department of Otorhinolaryngology-Head and Neck Surgery, University of Helsinki and Helsinki University Hospital, Helsinki, Finland. Division of Ear, Nose and Throat Diseases, Department of Clinical Sciences, Intervention and Technology, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden. Leivo Ilmo I Institute of Biomedicine, Pathology, University of Turku, Turku, Finland. eng Finnish Cancer Society Finnish Dental Society (Apollonia) Finska Läkaresällskapet Helsinki University Hospital Maritza and Reino Salonen Foundation Turku University Hospital Fund Journal Article Review 2020 06 17 United States Head Neck 8902541 1043-3074 IM N classification T classification TNM stage depth of invasion (DOI) eighth edition American Joint Committee on Cancer (AJCC 8) extranodal extension oral squamous cell carcinoma (OSCC) prognosis 2019 07 27 2020 04 23 2020 05 30 2020 6 18 6 0 2020 6 18 6 0 2020 6 18 6 0 aheadofprint 32548858 10.1002/hed.26344 REFERENCES, 2020</i></font><br><font color=#008000>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0<br></font></span><br>9.  <a href=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0 class=title>IL-15 and IL-23 synergize to trigger Th17 response by CLA<sup>+</sup> T cells in psoriasis.</a><a href=http://ubio.org/tools/linkit.php?map%5B%5D=all&link_type=2&url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0><img src=linkit.png border=0 title='LinkIT' alt='LinkIT'></a> <br><span class=j>de Jesús-Gil C, Ruiz-Romeu E, Ferran M, Sagristà M, Chiriac A, García P, Celada A, Pujol RM, Santamaria-Babí LF<br><font color=gray><i>Experimental dermatology Exp. Dermatol. IL-15 and IL-23 synergize to trigger Th17 response by CLA+ T cells in psoriasis. 10.1111/exd.14113 IL-15 has emerged as a potentially relevant target in the IL-17 response in psoriasis. However, its mechanism is poorly characterized in humans. IL-15 and IL-23 are constitutively expressed in the psoriatic lesion. Also, IL-15 is considered a susceptibility-associated gene in psoriasis, as are IL-23R, and HLACW6. Here, we studied the effect of IL-15 and IL-23 stimulation on the cytokine response of CLA+/CLA- T cells from 9 psoriasis patients and 3 healthy control subjects. To this end, CLA + and CLA- T cells from blood samples were cultured with epidermal cells from skin biopsies and treated with IL-15 and IL-23. After five days of culture, cytokines in supernatant were measured by ELISA or fluorescent bead-based immunoassay. There was a statistically significant increase in IL-17F and IL-17A production (P < .001) in cocultures of psoriasis skin-homing CLA + T cells with epidermal cells when stimulated with IL-15 and IL-23, but this effect was not observed in the cells of healthy controls. Interestingly, this response was reduced by around 50 to 80% by blocking HLA class I and II molecules. Our results point to the synergic action of IL-15 and IL-23 selectively for CLA + cells in psoriasis, leading to the induction of Th17 cell-related cytokines. © 2020 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd. de Jesús-Gil Carmen C Translational Immunology, Department of Cellular Biology, Physiology and Immunology, Faculty of Biology, Universitat de Barcelona, Spain. Ruiz-Romeu Ester E Translational Immunology, Department of Cellular Biology, Physiology and Immunology, Faculty of Biology, Universitat de Barcelona, Spain. Ferran Marta M Department of Dermatology, Hospital del Mar Barcelona, Spain. IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain. Sagristà Marc M Department of Dermatology, Hospital del Mar Barcelona, Spain. IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain. Chiriac Anca A Department of DermatoPhysiology, Apollonia University, Iasi, Romania. Dermatology Department, Nicolina Medical Center, Iasi, Romania. García Pablo P Department of Dermatology, Hospital del Mar Barcelona, Spain. IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain. Celada Antonio A Macrophage Biology, Department of Cellular Biology, Physiology and Immunology, Faculty of Biology, Universitat de Barcelona, Spain. Pujol Ramon M RM Department of Dermatology, Hospital del Mar Barcelona, Spain. IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain. Santamaria-Babí Luis F LF https://orcid.org/0000-0002-1674-6654 Translational Immunology, Department of Cellular Biology, Physiology and Immunology, Faculty of Biology, Universitat de Barcelona, Spain. eng European Regional Development Fund FPU13/02308 Ministerio de Educación, Cultura y Deporte of the Spanish Government FI-2018 Agency for Management of University and Research Grants of the Generalitat de Catalunya European Regional Development Found (ERDF) PI09/2222 FIS/ISCIII 2013 (Ministerio de Economía y Competitividad e Instituto de Salud Carlos III PI13/01845 FIS/ISCIII 2013 (Ministerio de Economía y Competitividad e Instituto de Salud Carlos III PI13/01716 FIS/ISCIII 2013 (Ministerio de Economía y Competitividad e Instituto de Salud Carlos III PI16/01573 FIS/ISCIII 2016 PI016/00532 FIS/ISCIII 2016 Journal Article 2020 05 31 Denmark Exp Dermatol 9301549 0906-6705 IM CLA IL-15 IL-23 Th17 psoriasis 2020 01 02 2020 04 24 2020 05 04 2020 6 2 6 0 2020 6 2 6 0 2020 6 2 6 0 aheadofprint 32476200 10.1111/exd.14113 REFERENCES, 2020</i></font><br><font color=#008000>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0<br></font></span><br>10.  <a href=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0 class=title>Cutaneous signs in COVID-19 patients: A review.</a><a href=http://ubio.org/tools/linkit.php?map%5B%5D=all&link_type=2&url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0><img src=linkit.png border=0 title='LinkIT' alt='LinkIT'></a> <br><span class=j>Wollina U, Karada? AS, Rowland-Payne C, Chiriac A, Lotti T<br><font color=gray><i>Dermatologic therapy, 2020</i></font><br><font color=#008000>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0<br></font></span><br><br><br><table cellspacing=0 cellpadding=0 align=center><tr valign=bottom><td align=center><img src=p.png border=0></td><td align=center><img src=o_red.png border=0></td><td align=center><a href=http://ubio.org/portal/index.php?search=Apollonia&category=l&client=pubmed&startPage=2><img src=o_yellow.png border=0></a></td><td align=center><a href=http://ubio.org/portal/index.php?search=Apollonia&category=l&client=pubmed&startPage=3><img src=o_yellow.png border=0></a></td><td align=center><a href=http://ubio.org/portal/index.php?search=Apollonia&category=l&client=pubmed&startPage=4><img src=o_yellow.png border=0></a></td><td align=center><a href=http://ubio.org/portal/index.php?search=Apollonia&category=l&client=pubmed&startPage=5><img src=o_yellow.png border=0></a></td><td align=center><a href=http://ubio.org/portal/index.php?search=Apollonia&category=l&client=pubmed&startPage=6><img src=o_yellow.png border=0></a></td><td align=center><a href=http://ubio.org/portal/index.php?search=Apollonia&category=l&client=pubmed&startPage=7><img src=o_yellow.png border=0></a></td><td align=center><a href=http://ubio.org/portal/index.php?search=Apollonia&category=l&client=pubmed&startPage=8><img src=o_yellow.png border=0></a></td><td align=center><a href=http://ubio.org/portal/index.php?search=Apollonia&category=l&client=pubmed&startPage=9><img src=o_yellow.png border=0></a></td><td align=center><a href=http://ubio.org/portal/index.php?search=Apollonia&category=l&client=pubmed&startPage=10><img src=o_yellow.png border=0></a></td><td align=center><a href=http://ubio.org/portal/index.php?search=Apollonia&category=l&client=pubmed&startPage=2><img src=rtal.png border=0></a></td></tr><td align=center></td><td align=center>1</td><td align=center><a href=http://ubio.org/portal/index.php?search=Apollonia&category=l&client=pubmed&startPage=2>2</a></td><td align=center><a href=http://ubio.org/portal/index.php?search=Apollonia&category=l&client=pubmed&startPage=3>3</a></td><td align=center><a href=http://ubio.org/portal/index.php?search=Apollonia&category=l&client=pubmed&startPage=4>4</a></td><td align=center><a href=http://ubio.org/portal/index.php?search=Apollonia&category=l&client=pubmed&startPage=5>5</a></td><td align=center><a href=http://ubio.org/portal/index.php?search=Apollonia&category=l&client=pubmed&startPage=6>6</a></td><td align=center><a href=http://ubio.org/portal/index.php?search=Apollonia&category=l&client=pubmed&startPage=7>7</a></td><td align=center><a href=http://ubio.org/portal/index.php?search=Apollonia&category=l&client=pubmed&startPage=8>8</a></td><td align=center><a href=http://ubio.org/portal/index.php?search=Apollonia&category=l&client=pubmed&startPage=9>9</a></td><td align=center><a href=http://ubio.org/portal/index.php?search=Apollonia&category=l&client=pubmed&startPage=10>10</a></td><td align=center><a href=http://ubio.org/portal/index.php?search=Apollonia&category=l&client=pubmed&startPage=2>»</a></td></tr></table></table></tr></table></td><script src="http://www.google-analytics.com/urchin.js" type="text/javascript"> </script> <script type="text/javascript"> _uacct = "UA-634822-1"; urchinTracker(); </script> </BODY> </HTML>